Profound Medical (PROF) Invested Capital (2018 - 2026)

Profound Medical has reported Invested Capital for 7 years, with the latest figure at $58.8 million in Q2 2026.

• On a quarterly basis, Invested Capital rose 34.54% year-over-year to $58.8 million in Q2 2026; TTM through Jun 2026 was $58.8 million, a 34.54% increase from a year earlier, with the FY2025 full-year figure at $70.9 million, up 6.16% from the prior year.
• Invested Capital was $58.8 million for Q2 2026 at Profound Medical, down from $68.4 million in the prior quarter.
• The five-year high for Invested Capital was $70.9 million in Q4 2025, with the low at $40.4 million in Q4 2023.
• Average Invested Capital over 5 years is $56.2 million, with a median of $58.8 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2024: Invested Capital tumbled 32.94% in 2023, then jumped 65.27% in 2024.
• Over 5 years, Invested Capital stood at $60.3 million in 2022, then tumbled by 32.94% to $40.4 million in 2023, then jumped by 65.27% to $66.8 million in 2024, then increased by 6.16% to $70.9 million in 2025, then declined by 17.07% to $58.8 million in 2026.
• The last three Invested Capital figures came in at $58.8 million (Q2 2026), $68.4 million (Q1 2026), and $70.9 million (Q4 2025), per Business Quant data.